An act relating to the 340B prescription drug pricing program

This Vermont bill (H 266) strengthens protections for hospitals and pharmacies participating in the federal 340B drug pricing program. It prohibits drug manufacturers from discriminating against 340B-covered entities or their contract pharmacies (e.g., by restricting access to discounted drugs or demanding excessive data), and requires manufacturers to offer 340B discounts at the time of purchase instead of deferred rebates. The bill also mandates annual reporting by participating hospitals on 340B drug costs, payments received, and how revenue supports community care programs. These provisions apply to Vermont hospitals using the federal 340B program and their contracted pharmacies, effective immediately after the governor signed it on June 11, 2025.